EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Intravenous Tranexamic Acid in Rhinoplasty: A Randomized Controlled Trial

Elizabeth S Longino, Nicole G Desisto, Feyi Adegboye, Emily Rebula, Naweed I Chowdhury, Priyesh N Patel iD, Scott J Stephan, Shiayin F Yang iD

Facial Plastic Surgery & Aesthetic Medicine · 01.01.2026 · 28 (1) · 87-94

DOI: 10.1089/fpsam.2024.0327 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Facial Plastic Surgery & Aesthetic Medicine, online erschienen am 05.03.2025. Verfasst von Elizabeth S Longino und 7 weiteren Autor:innen. Beteiligte Einrichtung: Otolaryngology & Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Tranexamic Acid, Rhinoplasty, Antifibrinolytic Agents, Blood Loss, Surgical. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Existing data on tranexamic acid (TXA) in rhinoplasty are mixed.

Objective

Compare blood loss, edema, and bruising in patients undergoing septorhinoplasty with or without intravenous (IV) TXA, measured by estimated blood loss and photograph review of edema/ecchymosis.

Design

Randomized controlled trial (NCT05774717).

Methods

Patients undergoing open septorhinoplasty were eligible. Participants were randomized to receive 1 g IV TXA preoperatively or routine medications only. Intraoperative bleeding was measured using the Boezaart scale and sponge saturation. Patients rated periorbital edema/ecchymosis at 1 week. Photos were reviewed by a facial plastic surgeon to grade edema/ecchymosis.

Results

There were 139 participants: 73 (53%) female, mean age of 42 ± 15 years, and 13% revision procedures. Sixty-nine (50%) received TXA. Boezaart scores were 2.25 and 2.41 ( p = 0.3), and sponge scores were 0.76 and 0.84 ( p = 0.4) in the TXA and control groups, respectively. Postoperative edema/ecchymosis were 1.15/1.19 out of 4 in the TXA group, and 0.97/1.05 in the control group. Surgeon-graded edema/ecchymosis were 1.78/1.76 (TXA) and 1.82/1.86 (control). There was no difference in epistaxis, pain, or appearance satisfaction.

Conclusions

In this study, there was no difference in bleeding, edema, ecchymosis, or postoperative experience associated with TXA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tranexamic AcidRhinoplastyAntifibrinolytic AgentsBlood Loss, SurgicalHumansFemaleAdultMaleEcchymosisEdemaMiddle AgedContusionsAdministration, Intravenous

Substanzen

Tranexamic AcidAntifibrinolytic Agents

Autor:innen und Institutionen

  • Otolaryngology & Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

ORCID-Profile: Priyesh N Patel, Shiayin F Yang

Zitieren

APA

Longino, E. S., Desisto, N. G., Adegboye, F., Rebula, E., Chowdhury, N. I., Patel, P. N., Stephan, S. J., & Yang, S. F. (2026). Intravenous Tranexamic Acid in Rhinoplasty: A Randomized Controlled Trial. Facial Plastic Surgery & Aesthetic Medicine, 28(1), 87-94. https://doi.org/10.1089/fpsam.2024.0327

Vancouver

Longino ES, Desisto NG, Adegboye F, Rebula E, Chowdhury NI, Patel PN, et al. Intravenous Tranexamic Acid in Rhinoplasty: A Randomized Controlled Trial. Facial Plastic Surgery & Aesthetic Medicine. 2026;28(1):87-94. doi:10.1089/fpsam.2024.0327

BibTeX
@article{Longino2026,
  author = {Longino, Elizabeth S and Desisto, Nicole G and Adegboye, Feyi and Rebula, Emily and Chowdhury, Naweed I and Patel, Priyesh N and Stephan, Scott J and Yang, Shiayin F},
  title = {Intravenous Tranexamic Acid in Rhinoplasty: A Randomized Controlled Trial},
  journal = {Facial Plastic Surgery & Aesthetic Medicine},
  year = {2026},
  volume = {28},
  number = {1},
  pages = {87--94},
  doi = {10.1089/fpsam.2024.0327}
}
Kostenlos starten →